What’s already known?
- There is conflicting evidence over the expression of IL-35 in patients
with psoriasis;
- Data from registries to date suggest that IL-35 has an
immunosuppressive function in psoriasis model;
- The immune function of MDSC is completely different in diseases of
different backgrounds